SCIENTIFIC PROGRAMME

Interactive Planner

Full details of the congress programme are available in the online planner – click on the button below to access the planner.

You can browse the entire scientific programme, search for sessions, chairs and speakers and create your own personal itinerary by selecting your favourite sessions. You can also download the programme for any session.

Start building your own itinerary by adding sessions or presentations. Simply access the iPlanner, click on the session of your choice and click on “Favourite All” to add the whole session to your itinerary, or click on the star beside a presentation to add just this presentation from the session.

 

Programme Schedule

Click on the image below to view the programme schedule in pdf format.

The congress programme comprises plenary lectures, interactive sessions, specialty sessions and a comprehensive teaching programme. Details of sessions may be found below.

Information on the programme and sessions is updated regularly here and in the interactive planner.

The IEC 2019 increases the focus on educational sessions and courses. Besides the traditional morning educational sessions, the congress offers a series of whole-day and half-day courses, before the official opening ceremony. Each half-day course is repeated twice, once on the morning and once in the afternoon.

The courses target ILAE’s new list of competencies and learning objectives for epileptologists.

The half-day and full-day teaching courses may be added to your congress registration for an additional fee. More information on fees and availability of courses are available via the REGISTRATION SYSTEM.

Half-day Teaching Course: EEG in diagnosing patients with epilepsy (EEG starter)

Co-chairs: Sándor Beniczky (Denmark) & Ronit Pressler (United Kingdom)

  • Basic technology, electrodes, montages and localizationSándor Beniczky (Denmark)
  • Systematic approach to EEG interpretation: background activity – Ronit Pressler (United Kingdom)
  • Systematic approach to EEG interpretation: interictal and ictal patterns – Richard Wennberg (Canada)
  • Normal variants. Sensitivity and specificity – Ernest Somerville (Australia)

 

Half-day Teaching Course: Epilepsy diagnosis

Co-chairs: Peter Wolf (Denmark/Brazil) & Walter van Emde Boas (Netherlands)

  • Is this seizure? Recognizing and classifying seizures from patient history and from video recordings – Peter Wolf (Denmark)
  • Is this seizure? Recognizing and classifying seizures from patient history and from video recordings – Walter van Emde Boas (Netherlands)
  • Localizing focal seizures based on patient history and video recordings – Philippe Kahane (France)
  • Etiologies according to the age of onset – Renzo Guerrini (Italy)
  • Etiologies according to the age of onset – Michael Sperling (USA)
  • Epilepsy syndromes – Michalis Koutroumanidis (United Kingdom)
  • Epilepsy syndromes – Matthew Walker (United Kingdom)

 

Half-day Teaching Course: Pharmacological treatment: starter course

Co-chairs: Emilio Perucca (Italy) & Torbjörn Tomson (Sweden)

  • Basic pharmacology – Graeme  Sills (United Kingdom)
  • When to treat and not treat – CT Tan (Malaysia)
  • When to treat and not treat – Shih Hui Lim (Singapore)
  • Drug selection and titration – Emilio Perucca (Italy)
  • Special populations – Torbjörn Tomson (Sweden)
  • Special populations – Nicola Specchio (Italy)

 

Half-day Teaching Course: Status epilepticus

Chair: Eugen Trinka (Austria)

  • Epidemiology and classification – Manjari Tripathi (India)
  • Pathophysiology and consequences of status epilepticus – Jaideep Kapur (USA)
  • Diagnosis and treatment: part one – Eugen Trinka (Austria)
  • Diagnosis and treatment: part two – Adam Strzelczyk (Germany)

 

Full-day Teaching Course: Neuroimaging in epilepsy – what the clinician should know

Co-chairs: Paolo Federico (Canada) & Andrea Bernasconi (Canada)

  • Introduction to neuroimaging in epilepsy – Paolo Federico (Canada)
  • MRI physics, sequence names, and MRI epilepsy protocol – Boris Bernhardt (Canada)
  • Common epileptic pathologies: temporal epilepsy – Neda Ladbon Bernasconi (Canada)
  • Common epileptic pathologies: extratemporal lobe epilepsy – Fernando Cendes (Brazil)
  • MRI-negative epilepsy. What are the next steps? – Andrea Bernasconi (Canada)
  • Other neuroimaging modalities: PET, SPECT, etc. – Yotin Chinvarun (Thailand)
  • fMRI (task based, EEG-fMRI) and other advanced MRI methods – Graeme Jackson (Australia)
  • fMRI (task based, EEG-fMRI) and other advanced MRI methods – Anna Elisabetta Vaduano (Italy)

 

Teaching Course: EEG source imaging – part one: theory

  • Stefan Rampp (Germany)
  • Sándor Beniczky (Denmark)

 

Teaching Course: EEG source imaging – part two: hands-on

  • Sándor Beniczky (Denmark)
  • Stefan Rampp (Germany)

 

Teaching Course: Teaching course for neurophysiology technicians

Chair: Sándor Beniczky (Denmark)

  • Sándor Beniczky (Denmark)
  • Christian Skaarup (Denmark)
  • Anders Bach Justesen (Denmark)

 

Teaching Session: Counselling patients with epilepsy, caregivers and relatives

  • Martin Brodie (Scotland)
  • Mary Secco (Canada)

 

Teaching Session: Focal cortical dysplasia: an update

  • Imad Najm (USA)
  • Ingmar Blümcke (Germany)

 

Teaching Session: Autoimmune epilepsy – clinical diagnosis and treatment: a practical approach

Chair: Jeffrey Britton (USA)

  • Clinical clues – Avi Gadoth (Israel)
  • EEG features – Xia-Qui Shao (China)
  • Radiologic findings – Andrew McKeon (USA)
  • What’s the score? Aids to diagnosis and treatment – Jeffrey Britton (USA)

 

Teaching Session: Video session: is this epilepsy or not?

  • Jo Wilmshurst (South Africa)
  • Hal Blumenfeld (USA)
  • Ivan Rektor (Czech Republic)

 

Teaching Session: Video session: focal seizures

  • Philippe Kahane (France)
  • Philippe Ryvlin (Switzerland)

 

Teaching Session: Video session: generalized seizures

  • Ronit Pressler (United Kingdom)
  • Guido Rubboli (Denmark)

 

Teaching Session: VIREPA courses: EEG (basic and advanced)

  • Elena Gardella (Denmark)
  • Michalis Koutroumanidis (United Kingdom)

 

Teaching Session: VIREPA courses: sleep and paediatric EEG

  • Al de Weerd (Germany)
  • Dana Craiu (Romania)

 

Teaching Session: Epileptic encephalopathies

  • Epileptic encephalopathy: definition and physiopathology – Ingrid Scheffer (Australia)
  • Genetic and metabolic investigation: the impact for patients care – Rima Nabbout (France)
  • Treatment of epileptic encephalopathy – J Helen Cross (United Kingdom)

Presidential Symposium: Predicting the future of epilepsy

Co-chairs: Samuel Wiebe (Canada) & Martin Brodie (Scotland)

  • Algorithms in clinical practice – can they really help us predict outcomes? – Lara Jehi (USA)
  • Intelligent neuro-devices – present and future – Mark Cook (Australia)
  • Machine learning and artificial Intelligence – is the future already here? – Philippe Ryvlin (Switzerland)
  • Precision medicine and epilepsy therapies of the future – Sanjay Sisodiya (United Kingdom)
  • Epilepsy care in resource limited countries – what does the future hold? – Angelina Kakooza (Uganda)

 

Challenges and solutions in providing epilepsy care

Chair:  Ernest Somerville (Australia)

  • State of the art, have we moved forward? – Martin Brodie (Scotland)
  • It really is more than seizures – Kousuke Kanemoto (Japan)
  • You’re drug resistant… now what? – Ernest Somerville (Australia)
  • Moving beyond the clinic – Mary Secco (Canada)

 

Infection, inflammation and epilepsy

Chair:  Jeffrey Britton (USA)

  • The clinical diagnosis of autoimmune encephalopathies – Christian Bien (Germany)
  • Humoral factors in the pathophysiology of seizures and status epilepticus – Angela Vincent (United Kingdom)
  • Infections and autoimmunity in epilepsy – Russell Dale (Australia)
  • Treatment options in autoimmune epilepsy syndromes – Andrew McKeon (USA)

 

Improving outcomes in drug resistant childhood epilepsy: what more can we do?

Chair:  Marilisa Guerreiro (Brazil)

  • Consequences of drug resistant epilepsies – Elaine Wirrell (USA)
  • Improving outcomes in early onset epilepsies – Jo Wilmshurst (South Africa)
  • Innovations in the detection of epileptogenic zone – Ana Carolina Coan (Brazil)
  • Optimising learning and behavioural potential – Colin Reilly (Sweden)

 

Novel therapies in epilepsy: a brave new world

Chair:  Lieven Lagae (Belgium)

  • Precision medicine: academic dreaming or clinical reality? – Samuel Wiebe (Canada)
  • Stop epileptogenesis before the seizures start: preventive treatment of epilepsy – Terence O’Brien (Australia)
  • Only treat when there are seizures: closed loop systems in epilepsy – Esther Krook Magnuson (USA)
  • Change the brain, stop the seizures: stem cells and genetic therapies in epilepsy – Simon Waddington (United Kingdom)

 

Applied technology in the future of epilepsy

Co-chairs:  Sándor Beniczky (Denmark) & Mark Cook (Australia)

  • Seizure detection based on movement: EMG and accelerometery – Sándor Beniczky (Denmark)
  • Seizure detection based on autonomic changes: ECG and electrodermal activity – Gregory Krauss (USA)
  • Therapeutic wearable devices – Mark Cook (Australia)
  • Wearable devices for SUDEP prevention  – Philippe Ryvlin (Switzerland)

WONOEP Symposium

Co-chairs: Aristea Galanopoulou (USA) & Terence O’Brien (Australia)

  • What is focal seizure?  –  Astrid Nehlig (France)
  • What is generalized seizure?  – Terence O’Brien (Australia)
  • What is seizure in immature animals?  – Aristea Galanopoulou (USA)
  • Borderland of epileptic and non-epileptic events  – Ozlem Akman (Turkey)

 

Application of genetic studies in epilepsy care: genome wide association studies

Co-chairs: Gianpiero Cavalleri (Ireland) & Sam Berkovic (Australia)

  • An introduction to genome-wide association studies for clinicians – Nigel Tan (Singapore)
  • Common variants in common epilepsies: mega-analysis of >15,000 epilepsy cases – Remi Stevelink (Netherlands)
  • Predicting drug reactions with genotyping: HLA antigens, drug reactions and ethnicity – Patrick Kwan (Australia)
  • Predicting drug reactions with genotyping: other genes and drug reactions – Mark McCormack (Ireland)
  • Can genetic information help predict response to AED therapy? – Iscia Lopes-Cendes (Brazil)
  • General discussion: who and when to test in 2019

 

Childhood comorbidities from mechanism to management

Co-chairs: Dana Craiu (Romania) & Chahnez Triki (Tunisia)

  • Epilepsy and autism – Dana Craiu (Romania)
  • Impulse control – Naoufel Gaddour (Tunisia)
  • Cognitive impairment – Lieven Lagae (Belgium)
  • Mood disorders – Edward Kija (Tanzania)

 

Impaired consciousness/awareness in epilepsy: clinical spectrum and mechanistic approaches

Co-chairs: Hal Blumenfeld (USA) & Satish Jain (India)

  • What is “impaired awareness” and why is it important? – Sameer Zuberi (United Kingdom)
  • Dissociating unresponsiveness from unconsciousness during epileptic seizures – Melanie Boly (Belgium)
  • Electrophysiological correlates of impaired consciousness during focal seizures – Fabrice Bartolomei (France)
  • Probing cortico-subcortical networks to reverse unconsciousness during epileptic seizures – Hal Blumenfeld (USA)

 

Making the right treatment choices in newly diagnosed epilepsy

Co-chairs: Tony Marson (United Kingdom) & Hazel Paragua-Zuellig (Philippines)

  • The comparative clinical effectiveness of first line AEDS – Tony Marson (United Kingdom)
  • Clinically important harms associated with AEDs – Nathalie Jette (USA)
  • Assessing benefit-harm trade-offs in order to make best treatment choices? – Reetta Kälviäinen (Finland)
  • Making cost effective treatments available – Hazel Paragua-Zuellig (Philippines)

 

Optimising management of epilepsy in pregnancy

Co-chairs: Sanjeev Thomas (India) & Torbjörn Tomson (Sweden)

  • Current global guidelines for the management of epilepsy in pregnancy: results of an ILAE survey – Torbjörn  Tomson (Sweden)
  • Update on developmental and behavioural outcomes after foetal exposure to different AEDs – Kimford Meador (USA)
  • Managing epilepsy treatment during pregnancy with current knowledge and limited resources – Sanjeev Thomas (India)

 

Autoimmune epilepsies – mechanisms, clinical spectra and treatment

Co-chairs: Christian Bien (Germany) & Sarosh Irani (United Kingdom)

  • Clinical scoring systems in identifying autoimmune epilepsy and selection of patients for treatment – Andrew McKeon (USA)
  • Epilepsy and seizures in systemic autoimmune disorders – Jeffrey Britton (USA)
  • Neural antibody-mediated syndromes presenting with seizures – Sarosh Irani (United Kingdom)
  • NORSE and autoimmune status epilepticus – Russell Dale (Australia)

 

Key neuropsychiatric issues in epilepsy in a neurological clinical setting

Co-chairs: Kousuke Kanemoto (Japan) & Mike Kerr (United Kingdom)

  • Clinical assessment of the key psychiatric comorbidities in adults with epilepsy – Mike Kerr (United Kingdom)
  • Clinical assessment of the key psychiatric comorbidities in children with epilepsy – Kette Valente (Brazil)
  • Suicide in epilepsy – from ideation to planning – how can a neurologist address and help to prevent?  – Jakob Christensen (Denmark)
  • Treating psychiatric disorders in people with epilepsy: what do we really know? – Kousuke Kanemoto (Japan)

 

Making an impact by empowering persons with epilepsy

Co-chairs: Mary Secco (Canada) & Francesca Sofia (Italy)

  • I am an advocate – Shenaz Haveliwala (India)
  • The power of engagement campaigns – Philip Gattone (USA)
  • Impact of partnering for research – Francesca Sofia (Italy)
  • Impacting policy and legislation – Meredith Fendt-Newlin (Switzerland)

 

Small patients – big challenges: neonatal seizures

Co-chairs: Suwannee Phancharoen (Thailand) & Ronit Pressler (United Kingdom)

  • Neonatal seizures – gaps in knowledge – Ronit Pressler (United Kingdom)
  • ILAE classification of neonatal seizures – Elissa Yozawitz (USA)
  • Update of neonatal seizure guidelines – Hans Hartman (Germany)
  • Treatment of neonatal seizures, where are we now? – Angelina Kakooza (Uganda)

 

Neurobiology Symposium: Biological rhythms that modulate the risk of seizures

Co-chairs:  Aristea Galanopoulou (USA) & Christophe Bernard (France)

  • Rhythms modulating seizure risk in human epilepsies – Maxime Baud (Switzerland)
  • Circadian control of seizures and seizure forecasting – Philippa Karoly (Australia)
  • Circadian regulation in the pathophysiology and treatment of temporal lobe seizures – Christophe Bernard (France)
  • Loss of CLOCK underlies focal epilepsies – Judy Liu (USA)

 

Epilepsy in adolescents

Co-chairs:  Choong Yi Fong (Malaysia) & Suwannee Phancharoen (Thailand)

  • Puberty and epilepsy – Alexis Arzimanoglou (France)
  • Diagnosis and management – Choong Yi Fong (Malaysia)
  • Lifestyle – Jaime Carrizosa (Colombia)
  • The need for transition programs – Danielle Andrade (Canada)

 

Imaging epileptogenesis of epilepsy across the lifespan

Co-chairs:  Neils Focke (Germany) & Dong Zhou (China)

  • Molecular imaging biomarkers of epileptogenesis – Heidrun Potschka (Germany)
  • Prenatal imaging of epileptogenic lesions – Gregor Kasprian (Austria)
  • Challenges of investigating epilepsy in the developing brain – Jonathan O’Muircheartaigh (United Kingdom)
  • Imaging phenotypes in epilepsy – Neils Focke (Germany)

 

Pros and cons of AED withdrawal

Co-chairs:  Morten Ingvar Lossius (Norway) & Byungin Lee (Korea, Republic of)

  • When is it worth the risk? – Morten Ingvar Lossius (Norway)
  • AED withdrawal in adults – Byungin Lee (Republic of Korea)
  • AED withdrawal in children – Marilisa Guerreiro (Brazil)
  • AED withdrawals after epilepsy surgery in children and adults – Kees Braun (Netherlands)

 

Update on the management of status epilepticus

Co-chairs:  Hannah Cock (United Kingdom) & Somsak Tiamkao (Thailand)

  • Definitions and timing of treatment – Satish Jain (India)
  • The out of hospital setting – Federico Vigevano (Italy)
  • What is the best first line treatment in hospital setting – Hannah Cock (United Kingdom)
  • Optimising management in resource poor settings – Somsak Tiamkao (Thailand)

 

Update on treatments of childhood epilepsies

Co-chairs:  Tayard Desudchit (Thailand) & Heung Dong Kim (Korea, Republic of)

  • Surgery and devices – Tayard Desudchit (Thailand)
  • Diet – Suvasini Sharma (India)
  • Cannabinoids – Kelly Knupp (USA)
  • Drugs in the pipeline – J Helen Cross (United Kingdom)

 

Epilepsy in the elderly

Co-chairs:  Naoki Akamatsu (Japan) & Martin Brodie (Scotland)

  • Epidemiology of elderly epilepsy – Alla Guekht (Russian Federation)
  • Challenges of epilepsy diagnosis in elderly people – Martin Brodie (Scotland)
  • Epilepsy and the challenges of longevity – Naoki Akamatsu (Japan)
  • Treatment and drug interactions – Eugen Trinka (Austria)

 

Epilepsy surgery: the cutting edge and level of evidence

Co-chairs:  Jeffrey Britton (USA) & Shih Hui Lim (Singapore)

  • Evidence-based novel neurophysiology – Julia Jacobs (Germany)
  • Diagnostic imaging and multimodal integration – Petr Marusic (Czech Republic)
  • Insular epilepsies – Philippe Kahane (France)
  • New therapeutic technologies (focused ultrasound, laser therapy, SEEG, RF ablation and others) – Michael Sperling (USA)

 

Moving beyond the medical management of epilepsy

Co-chairs:  Ding Ding (China) & Graeme Shears (Australia)

  • Epilepsy and social justice – Jacob Mugumbate (Zimbabwe)
  • Implementing school programs – Michelle Franklin (Canada)
  • Patient and family education – Carol D’Souza (India)
  • Training and employment – Li Min Li (Brazil)

 

Neuropsychology: implications for epilepsy surgery

Co-chairs:  Sallie Baxendale (United Kingdom) & Christoph Helmstaedter (Germany)

  • Standardising paradigms for pre-surgical evaluation – Christoph Helmstaedter (Germany)
  • Red flags: cognitive contraindications to surgery – Sallie Baxendale (United Kingdom)
  • Rehabilitation and the potential for plasticity and cognitive recovery – Sarah Wilson (Australia)
  • Imaging techniques to assess language and memory – Graeme Jackson (Australia)

Following the success of the ‘ASK THE EXPERT’ sessions at the 32nd International Epilepsy Congress, Barcelona 2017, the SOC are pleased to announce they will also take place at the IEC 2019 – but in a slightly different format!

Delegates were asked to submit interesting cases for discussion on three topics and a diploma will be provided to every delegate submitting a case for discussion. The submission system is now closed.

Two persons (experts) are responsible for each topic. The session with the selected cases will be written up as a thematic didactic paper for Epileptic Disorders and for every case included the presenter (one-two persons) will be co-author of the publication.

The ‘Ask the expert’ sessions are:

Women issues

  • Kimford Meador (USA) & Sanjeev Thomas (India)

Treat this

  • Lieven Lagae (Belgium) & Ernest Somerville (Australia)

Diagnose/classify this

  • Sameer Zuberi (United Kingdom) & Reetta Kälviäinen (Finland)

 

Please email any queries to IEC2019@epilepsycongress.org

Can we rely upon fMRI to localize language and memory when planning epilepsy surgery?

Chair:  Graeme Jackson (Australia)

  • Yes – Paolo Federico (Canada)
  • No – Meneka Sidhu (United Kingdom)

 

Should laser interstitial thermal ablation be the treatment of first choice for patients with mesial temporal sclerosis?

Chair:  Shih Hui Lim (Singapore)

  • Yes – Michael Sperling (USA)
  • No – Mario Alonso (Mexico)

 

Can epileptic and psychogenic seizures be more reliably diagnosed in the era of the smartphone?

Chair:  Elaine Wirrell (USA)

  • Yes – Manjari Tripathi (India)
  • No – Jo Wilmshurst (South Africa)

 

Should we recommend medical marijuana for treatment of uncontrolled focal seizures?

Chair:  Michael Sperling (USA)

  • Yes – Martin Brodie (Scotland)
  • No – Emilio Perucca (Italy)

 

Do the new classifications of seizures and epilepsy improve our ability to classify, diagnose, and treat epilepsy in the clinic?

Chair:  Ivan Rektor (Czech Republic)

  • Yes – Ingrid  Scheffer (Australia)
  • No – Felix Rosenow (Germany)

 

Is it advisable to taper medication in well-controlled patients with symptomatic adult-onset focal epilepsy?

Chair: Patrick Kwan (Australia)

  • Yes – KP Vinayan (India)
  • No  – Alejandro De Marinis (Chile)

Talking Shops are a new programme initiative for the IEC 2019. Created by special interest groups, these interactive sessions cover several specialties.

Treatment advances in the childhood epilepsies

Co-chairs: Lieven Lagae (Belgium) & Stéphane Auvin (France)

  • Gaps in knowledge regarding treatment in infants and young children with epilepsy – Julia Jacobs (Germany)
  • New approved treatments: Are they beneficial in childhood epilepsy? – Christoph Schöne-Bake (Germany)
  • Surgical approaches: It’s never too early to think about epilepsy surgery in young children with epilepsy – Georgia Ramantani (Switzerland)
  • Typical case scenarios: Treatment possibilities – KP Vinayan (India)

 

Access to treatment in resource-poor countries

Chair:  Timothy Welty (USA)

  • Introduction, generic medications – Timothy Welty (USA)
  • Accessibility to antiepileptic drugs – Ornella Ciccone (Italy)
  • Economic and political issues – Hazel Paragua-Zuellig (Philippines)
  • Potential solutions – Archana Patel (USA)

 

Developing prevention treatments for pediatric epilepsies: from models to the clinic

Chair: Aristea Galanopoulou (USA)

  • Preventing pediatric epilepsies when the cause is unknown: the West syndrome paradigm – Hiroki Nariai (USA)
  • Preventing epilepsy in children when etiology is known: the case of Focal Cortical Dysplasia – Stéphanie Baulac (France)
  • Can the EEG predict pediatric epilepsy diagnosis and epileptogenesis? – Kees Braun (Netherlands)

 

The International Epilepsy Curriculum: Common errors and their solutions from a psychiatric/ psychological perspective

Co-chairs: Christian Brandt (Germany) & Rosa Michaelis (Germany)

  • Introduction – The international epilepsy curriculum as a patient-centered approach: an opportunity to increase awareness of common psychiatric conditions in epilepsy? – Rosa Michaelis (Germany)
  • Understand and address the culturally appropriate aspects and consequences of the diagnosis of epilepsy, including stigma (LO 2.1), from the Asian perspective –  Venus Tang (Hong Kong)
  • Appropriately manage and advise regarding psychiatric emergencies (e.g. suicidal ideation) (LO 5.1.5) and recognize when to refer adult patients with psychiatric comorbidities for higher level of care (LO 2.5) – W Curt LaFrance Jr (USA) & Milena Gandy (Australia)
  • Provide counseling specific to children with epilepsy and their parents regarding lifestyle matters (LO 2.9) and recognize when to refer paediatric patients with psychiatric comorbidities for higher level of care (LO 2.5) – Avani Modi (USA) & Janelle Wagner (USA) & Kette Valente (Brazil)
  • Provide counseling and information in relation to PNES to patients and families (LO 2.10): Markus Reuber (United Kingdom) & W Curt LaFrance Jr (USA)

 

Individualized medicine for persons with epilepsy and intellectual disability – are we already there?

Co-chairs:  Christian Brandt (Germany) & Mike Kerr (United Kingdom)

  • General needs of persons with epilepsy and ID: AED treatment – Francis Tan (country?)
  • General needs of persons with epilepsy and ID: behavioral issues – Kousuke Kanemoto (Japan)
  • First steps to personalized drug treatment in persons with epilepsy and ID – Christian Brandt (Germany)
  • Epilepsy surgery in persons with ID is personalized treatment – Candan Gurses (Turkey)
  • Panel: Danielle Andrade (Canada), Laura Guilhoto, Mike Kerr (United Kingdom)

 

Advocacy for epilepsy policies and programmes

Chair:  Jacob Mugumbate (Australia)

  • Strategies for Africa – Mary Secco (Canada)
  • Research evidence supporting advocacy – Ding Ding (China)
  • Targeting policy makers – Phillip Gattone (USA)
  • How to get funding for your programs – Graeme Shears (Australia)

 

Novel insights into NMDA receptors in epilepsy: exciting times ahead

Chair:  Matthias Koepp (United Kingdom)

  • GRIN genes affecting patient variants analyzed in 3D protein structure context – Dennis Lal (Germany/USA)
  • NMDA receptors in ictogenesis, epileptogenesis and seizure-related neuronal death – a double-edged sword – Matthew Walker (United Kingdom)
  • Imaging NMDA receptors in-vivo in people with epilepsy – Marian Galovic (Switzerland/ United Kingdom)
  • Clinical and laboratory evidence for NMDA receptor specific modulation by NMDAR-antibodies – Sarosh Irani (United Kingdom)

 

ILAE North America – Gaps and opportunities for collaboration (education, care, research, global health) in the region

Chair: Nathalie Jette (USA)

  • Epilepsy education in the North American region – existing opportunities – Jaideep Kapur (USA)
  • Epilepsy care – current state in the region and gaps to be filled – Amza Ali (Jamaica)
  • Epilepsy research in North America – how to enhance collaborative initiatives – Samuel Wiebe (Canada)
  • Global health in epilepsy – the North American experience  – Karen Parko (USA)

 

Ten things every neurologist needs to know about neuropsychological assessment in epilepsy

Chair:  Sallie Baxendale (United Kingdom)

  • Ten things every neurologist needs to know about neuropsychological assessment in epilepsy – Sallie Baxendale (United Kingdom) & Sarah Wilson (Australia) & Christoph Helmstaedter (Germany)
  • Panel discussion & audience Q&A – Sallie Baxendale (United Kingdom) & Sarah Wilson (Australia) & Christoph Helmstaedter (Germany)

 

West Syndrome: Updates in modern era: etiologies, diagnoses, and managements

Co-chairs:  Heung Dong Kim (Korea, Republic of) & Stéphane Auvin (France)

  • Diagnostic challenges of West syndrome – Heung Dong Kim (Korea, Republic of)
  • Genetic/metabolic etiologies in West syndrome – Aristea Galanopoulou (USA)
  • Evidence-based guideline update: medical treatment of infantile spasms – Stéphane Auvin (France)
  • Precision medicine for West syndrome in the genomic era  – Hoon-Chul Kang (Korea, Republic of)

 

Optimizing therapy for Dravet Syndrome: so many choices but what should I pick?

Chair:  Elaine Wirrell (USA)

  • Stiripentol in Dravet Syndrome – Elaine Wirrell (USA)
  • Cannabidiol in Dravet Syndrome – Anup Patel (USA)
  • Fenfluramine in Dravet Syndrome – An-Sofie Schoonjans (Belgium)
  • Is it time to update the treatment proposal – Rima Nabbout (France)
  • Panel and audience discussion  – Rima Nabbout (France), Elaine Wirrell (USA), Anup Patel (USA), An-Sofie Schoonjans (Belgium). Ingrid Scheffer (Australia), J Helen Cross (United Kingdom)

 

Treatment and research gap for children with epilepsy in low and middle income countries

Chair: Stéphane Auvin (France)

  • Challenges to access to care in LMIC – Jo Wilmshurst (South Africa)
  • Current research trends in children with epilepsy in LMIC – Stéphane Auvin (France)
  • Challenges to research in children with epilepsy in LMIC – Pauline Samia (Kenya)

 

ILAE-YES Career Development Session: How to navigate your career path in epilepsy

Chair: Marian Galovic (United Kingdom)

  • Esther Krook Magnuson: How I navigated my career – Esther Krook Magnuson (USA)
  • Patrick Kwan: How I navigated my career – Patrick Kwan (Australia)
  • Sarah Wilson: How I navigated my career – Sarah Wilson (Australia)
  • Pieter van Mierlo: How I navigated my career – Pieter van Mierlo (Belgium)
  • Podium discussion

 

Generalised epilepsy genetics: distinct syndromes or murky margins?

Chair: Nicola Specchio (Italy)

  • How do we currently define each syndrome? – Marina Trivisano (Italy)
  • What are clinical similarities and differences? – Kate Riney (Australia)
  • What are electrographic similarities and differences? – Nicola Specchio (Italy)
  • Should the definitions change? If so, how? –  Discussion: Elaine Wirrell (USA), Rima Nabbout (France), Nicola Specchio (Italy)

Award Symposium: IBE Golden Light Forum

Co-chairs: Martin Brodie (Scotland) & Ann Little (Ireland)

  • My Personal Story – Nina Mago (Uganda)
  • My Personal Story – Amirsoheyl Pirayeshfar (Iran)
  • My Personal Story – Emma Lovise Larsen (Norway)
  • My Personal Story – Rebecca McGhee (Scotland)
  • My Personal Story – Sofia Betanzo (Chile)
  • My Personal Story – Elizabeth Dueweke (USA)
  • My Personal Story – Mohammad Agus Rahmatulloh (Indonesia)
  • My Personal Story – Scarlett Paige (Australia)

 

Award Symposium: Michael Prize

Co-chairs: Iscia Lopes-Cendes (Brazil) & Julia Jacobs (Germany)

  • Navigating from germline to somatic mutations in the mTOR pathway landscape – Stephanie Baulac (France)
  • Sleep, Oscillations, and background EEG in human focal epilepsy – Birgit Frauscher (Canada)

 

Award Symposium: ‘Epileptic Disorders’ Prize

Co-chairs: Alexis Arzimanoglou (France) & Sándor Beniczky (Denmark)

  • Epileptic seizure semiology in different age groups – Guadalupe Fernandez-Baca Vaca (USA)

 

Award Symposium: ‘Epilepsia’ Prize – Basic Science

Co-chairs: Astrid Nehlig (France) & Michael Sperling (USA)

  • Corpus callosum low‐frequency stimulation suppresses seizures in an acute rat model of focal cortical seizures – Nicholas Couturier (USA)

 

Award Symposium: ‘Epilepsia’ Prize – Clinical

Co-chairs: Astrid Nehlig (France) & Michael Sperling (USA)

  • Thalamic volume reduction in drug‐naive patients with new‐onset genetic generalized epilepsy – Suejen Perani (Germany)

 

Award Symposium: ‘Epilepsia Open’ Prize – Basic Science

Co-chairs: Aristea Galanopoulou (USA) & Ronit Pressler (United Kingdom)

  • Regulation of seizures induced by stress and brain trauma through the intestinal microbiome – Jesus-Servando Medel-Matus (USA)

 

Award Symposium: ‘Epilepsia Open’ Prize – Clinical

Co-chairs: Dong Zhou (China) & Lara Jehi (USA)

  • Hidden in plain sight: revealing seizure risk with seizure diaries – Sharon Chiang (USA)

The ILAE Young Epilepsy Section (ILAE-YES) will host 3 brainstorming sessions and 3 career development sessions in the exhibition hall during the coffee breaks on Sunday, Monday and Tuesday. Details of the sessions are below.

 

ILAE-YES Brainstorming Session: Will artificial intelligence and machine learning replace the epileptologist? Computer intelligence in epilepsy

Moderator: Vadym Gnatkovsky (Italy)

  • Boris Bernhardt (Canada)

 

ILAE-YES Brainstorming Session: Towards an achievable patient-centered research roadmap: why, when and how

Moderator: Christos Lisgaras (USA)

  • Philippe Ryvlin (Switzerland)

 

ILAE-YES Brainstorming Session: Cannabinoids: high hopes for the treatment of epilepsy

Moderator: Simona Balestrini (United Kingdom)

  • J Helen Cross (United Kingdom)

 

ILAE-YES Career Development Session: How to write an effective abstract

Moderator: Sjoerd Vos (United Kingdom)

  • Nathalie Jette (USA)

 

ILAE-YES Career Development Session: How to choose an effective title and write a cover letter

Moderator: Mirja Steinbrenner (Germany)

  • Matthew Walker (United Kingdom)

 

ILAE-YES Career Development Session: How to plan a research project and find appropriate funding

Moderator: Katja Kobow (Germany)

  • Samden Lhatoo (USA)

Comorbidities

Co-chairs:  Yotin Chinvarun (Thailand) & Reetta Kälviäinen (Finland)

  • Between neurology and psychiatry´s frontiers: a neuroimaging volumetric study of mesial temporal lobe epilepsy with hippocampal sclerosis and comorbid lifetime depression – Nathália Stela Visoná de Figueiredo (Brazil)
  • Statin treatment can reduce incidence of early seizure in acute ischemic stroke: A propensity score analysis – Soichiro Matsubara (Japan)
  • Profoundly impaired white matter integrity and brain networks in temporal lobe epilepsy with psychosis: A diffusion MRI study – Daichi Sone (United Kingdom)
  • Prevalence of Neuronal Autoantibodies in Chronic Epilepsy – Fernando Cendes (Brazil)

 

Genetics 1

Co-chairs:  Sanjay Sisodiya (United Kingdom) & Danielle Andrade (Canada)

  • Genetic landscape of malformations of cortical development with refractory epilepsy in Taiwan – Yo-Tsen Liu (Taiwan, Republic of China)
  • Repeat expansion disorders enriched in an Australian and New Zealand Epi25 Year 1 epilepsy cohort – Mark F Bennett (Australia)
  • Generalized tonic seizures with autonomic signs are the hallmark of SCN8A Developmental and Epileptic Encephalopathy – Marina Trivisano (Italy)
  • Genetic Heterogeneity in Landau-Kleffner Syndrome – Adeline Ngoh (United Kingdom)

 

Neurophysiology

Co-chairs:  Jaideep Kapur (USA) & Richard Wennberg (Canada)

  • Contribution of cognitive tasks to routine EEG – Patricia Braga (Uruguay)
  • EEG as a prognostic marker in autoimmune encephalitis – Poornima Narayanan Nambiar (India)
  • Intrinsic electrophysiological property and seizure network of hypothalamic hamartoma in vivo – Di Wang (China)
  • Seizure semiology and EEG features in limbic encephalitis with anti-LGI1 antibodies: a multicenter observational cohort study – Sara Matricardi (Italy)

 

Paediatrics 1

Co-chairs:  Marilisa Guerreiro (Brazil) & Jo Wilmshurst (South Africa)

  • Translation and validation of the Thai version of health-related quality of life measure for children with epilepsy (CHEQOL-25) – Natcha Lueangapapong (Thailand)
  • Memory impairments in children with new-onset localization related epilepsy – Carolina Ciumas (France)
  • Prevention of epilepsy and its comorbidities in Tuberous Sclerosis Complex – Lieven Lagae (Belgium)
  • Azathioprine therapy in Rasmussen Syndrome: a single-centre experience – Serena Pellegrin (Italy)

 

Psychosocial issues 1

Co-chairs: Ornella Ciccone (Italy) & Li Min Li (Brazil)

  • Quality indicators for epilepsy management in China: the development of a tool to improve care – Weixi Xiong (China)
  • Mindfulness-based intervention to promote psychological wellbeing in people with epilepsy (PWE): A preliminary report of a randomized crossover study – Siew Tim Lai (Malaysia)
  • Prevalence and incidence of epilepsy in three regions of Nigeria: a cross-sectional door-to-door survey – Musa Mamman Watila (United Kingdom)
  • Availability of antiepileptic drugs: international survey from the ILAE Access to Treatment Task Force – Virginia Pironi (Italy)

 

Adult epileptology

Co-chairs:  Kimford Meador (USA) & Manjari Tripathi (India)

  • 18F-FDG-PET hypermetabolism in basal ganglia is associated with faciobrachial dystonic seizures (FBDS) in leucine-rich glioma-inactivated 1 autoimmune encephalitis (LGI1 AE) subjects – Qun Wang (China)
  • Epileptic phenotypes, treatment attitudes and long-term outcomes of autoimmune epilepsies: a multicenter observational cohort study – Sara Matricardi (Italy)
  • Adult-onset Rasmussen encephalitis: a long-term follow-up of 12 patients – Francesco Deleo (Italy)
  • Serum inflammatory markers in a large cohort of patients with epilepsies – Iscia Lopes-Cendes (Brazil)

 

Neuroimaging

Co-chairs:  Kees Braun (Netherlands) & Paolo Federico (Canada)

  • Cortical and subcortical morphometric markers of extra temporal cognitive impairment in temporal lobe epilepsy with hippocampal sclerosis – K Raghavendra (India)
  • Using Pulsed Arterial Spin Labelling MRI (PASL-MRI) as a Localizing Tool in Drug-Resistant Epilepsies – Tipakorn Tumnark (Thailand)
  • Multi-centre Epilepsy Lesion Detection (MELD) Project: a collaborative MRI cohort for the analysis of focal cortical dysplasias – Sophie Adler-Wagstyl (United Kingdom)
  • Pharmacoresistant seizures associate with widespread cortical thickness atrophy in temporal lobe epilepsy – Fernando Cendes (Brazil)

 

Status epilepticus

Co-chairs:  Gregory Krauss (USA) & Satish Jain (India)

  • Intranasal midazolam as initial in-hospital treatment for status epilepticus: A pharmaco-EEG cohort study – Lara Kay (Germany)
  • Characteristics of acute MRI examinations in focal non-convulsive status epilepticus – a retrospective analysis – Francesco Capecchi (Switzerland)
  • Electroconvulsive Therapy in the Treatment of Super Refractory Status Epilepticus Related to New Onset Refractory Status Epilepticus – Madeline Tuong- Vi Nguyen (USA)
  • Mortality in super refractory status epilepticus in children – Maggie Lo Yee Yau (Hong Kong)

 

Surgery

Co-chairs:  Felix Rosenow (Germany) & Mario Alonso (Mexico)

  • Responsive Neurostimulation in Focal Epilepsy – Dawn Eliashiv (USA)
  • Dynamic changes in episodic memory functional connectivity after anterior temporal lobe resection – Sarah Buck (United Kingdom)
  • Comparison of subdural grid electrodes and SEEG in patients with refractory epilepsy in four large European centers – Matea Rados (Netherlands)
  • Magnetic source imaging of eloquent cortex in patients with refractory epilepsy: Novel findings and neurosurgical implications – Rakesh Kumar Mishra (India)

 

Treatment

Co-chairs:  Tony Marson (United Kingdom) & tbc

  • Cannabidiol (CBD; 10 and 20 mg/kg/day) significantly reduces convulsive seizure frequency in children and adolescents with Dravet syndrome: Results of a dose-ranging, multi-center, randomised, double-blind, placebo-controlled trial (GWPCARE2) – Ian Miller (USA)
  • Safety and efficacy of adjunctive perampanel in paediatric patients (aged 4 to ˂12 years) with partial-onset seizures (POS) or primary generalised tonic-clonic seizures (PGTCS): final results from the 311 Core Study – Andras Fogarasi (Hungary)
  • Effect of concomitant enzyme-inducing anti-seizure drugs (EIASDs) on the safety and efficacy of adjunctive perampanel in patients aged 4 to ˂12 years with partial-onset seizures (POS): final results from the 311 Core Study – Steven Phillips (USA)
  • New ILAE/PERC Infant Epilepsy protocol – Stéphane Auvin (France)

 

Genetics 2

Co-chairs:  Patrick Kwan (Australia) & KP Vinayan (India)

  • Efficacy of voltage-gated sodium channel subtype selective compounds in a novel zebrafish model for Dravet syndrome – Wout Jan Weuring (Netherlands)
  • Epilepsy characteristics in Colombian infants with Congenital Zika Syndrome – Blanca Doris Rodriguez Clavijo (Colombia)
  • Characterization of focal and generalized epilepsy polygenic burden in 630,603 individuals – Costin Leu (USA)
  • Deep sequencing in paired brain and peripheral tissues reveals the contribution of somatic and germline mutations to intractable childhood epilepsy – Hoon-Chul Kang (Korea, Republic of)

 

ILAE-YES Best Presenter Award

Co-chairs:  Pablo Casillas-Espinosa (Australia) & Christos Lisgaras (USA)

  • Reduced network connectivity in STX1B loss-of-function directly relates to gene expression – Justus Marquetand (Switzerland)
  • Impact of hippocampus-sparing temporal-lobe epilepsy surgery on postoperative verbal memory performance – Niels Alexander Foit (Germany)
  • Functional Characterization of GRIN2A mutations in Landau-Kleffner Syndrome – Adeline Ngoh (United Kingdom)
  • The spectrum of orbito-frontal seizures: a stereo-electroencephalographic study – Concetta Luisi (Italy)

 

Neurophysiology / Basic sciences

Co-chairs:  Felix Rosenow (Germany) & Terence O’Brien (Australia)

  • Functional Analysis of Catastrophic Childhood Epilepsy Genes: The Epilepsy Zebrafish Project (EZP) – Scott Baraban (USA)
  • Phase amplitude coupling of low frequencies with high frequency oscillations localizes epileptogenic zone in magnetoencephalography (MEG) – GK Bhargava (India)
  • How do epileptic foci generate both spikes and seizures? – Kevin Staley (USA)
  • Video EEG with Suggestion (VEST) trial-Comparison of efficacy between suggestion methods during Video EEG recording: verbal suggestion in isolation and verbal suggestion along with cotton swab or tuning fork for inducing the paroxysmal event in children aged 5 to 18 years with suspected psychogenic nonepileptic seizures-a randomized controlled non-inferiority trial – Sheffali Gulati (India)

 

Paediatrics 2

Co-chairs:  Federico Vigevano (Italy) & Jaime Carrizosa (Colombia)

  • Spectrum of epileptic syndromes in severe epilepsies of infancy: a population-based study – Katherine Howell (Australia)
  • Comparison of 1981, 1989 and 2017 International League Against Epilepsy classification (ILAE) – David Asish Manchala (India)
  • Paediatric Status Epilepticus: identification of prognostic factors using the new ILAE classification – Nicola Pietrafusa (Italy)
  • DILT (Daily vs Intermittent LGIT) trial-Comparison of Efficacy of Daily and Intermittent Low Glycemic Index Therapy Diet among Children with Drug Resistant Epilepsy aged 1-15 years: A Randomized Controlled Non-inferiority Trial – Prateek Kumar Panda (India)

 

Psychosocial issues 2

Co-chairs:  Candan Gurses (Turkey) & Ding Ding (China)

  • Epilepsy educational software programme as a tool to improve the awareness, knowledge and attitude among Malaysian parents of children with epilepsy – Wei Kang Lim (Malaysia)
  • Fostering and Developing Sustainability: A Post-Implementation Survey of an Epilepsy Self-Management Program – Barbara Jobst (USA)
  • Co-occurrence of Psychosis & Epilepsy: A systematic review and meta-analysis of the epidemiology – Churl-Su Kwon (USA)
  • Language and communication abilities in temporal lobe epilepsy patients: right vs. left hemisphere’s processing – Silvia Kochen (Argentina)